Xintela xintela.se


Public lists: Medical Devices (6118)

Xintela is developing cell therapy products based on patented technology. The method is aimed at cell therapy following sports injuries or osteoarthritis.

Xintela is developing cell therapy products based on patented technology. The method is aimed at cell therapy following sports injuries or osteoarthritis.

Company (IPO / Went public)

Phone: +46 703 291871

Fax:

Scheelev├Ągen 8

Lund, SE-223 63
Sweden

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Xintela $0.9M Mar 22, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Xintela Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Monoclonal antibody capable of binding integrin alpha 10 beta 1 Sep 20, 2013 Jun 14, 2016 Patent
Integrin heterodimer and a subunit thereof Oct 15, 2012 Nov 25, 2014 Patent
Monoclonal antibody capable of binding integrin alpha 10 beta 1 Jul 28, 2011 Oct 22, 2013 Patent
Marker for stem cells and its use May 25, 2010 Jan 31, 2012 Patent
Antibody to an integrin heterodimer and/or a subunit thereof Feb 06, 2006 Nov 01, 2011 Patent
See all 9 patents